|
41. (Journal Article): Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice.
Soria B, Roche E, Berna G, Leon-Quinto T, Reig JA, Martin F ABSTRACT:
Embryonic stem (ES) cells display the ability to differentiate in vitro into a variety of cell lineages. Using a cell-trapping system, we have obtained an insulin-secreting cell cl...
|
»
Diabetes OD
»
Regeneration of Isle...
»
Stem Cells
»
Embryonic Stem Cells
»
Journal Article
submitted: May 19, 2005 |
|
42. (Journal Article): Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro.
Reubinoff BE, Pera MF, Fong CY, Trounson A, Bongso A ABSTRACT:
We describe the derivation of pluripotent embryonic stem (ES) cells from human blastocysts. Two diploid ES cell lines have been cultivated in vitro for extended periods while maint...
|
»
Diabetes OD
»
Regeneration of Isle...
»
Stem Cells
»
Embryonic Stem Cells
»
In Vitro Derivation ...
»
Journal Article
submitted: Apr 05, 2006 |
|
43. (Journal Article): Derivation of pluripotent stem cells from cultured human primordial germ cells.
Shamblott MJ, Axelman J, Wang S, Bugg EM, Littlefield JW, Donovan PJ, Blumenthal PD, Huggins GR, Gearhart JD ABSTRACT:
Human pluripotent stem cells would be invaluable for in vitro studies of aspects of human embryogenesis. With the goal of establishing pluripotent stem cell lines, gonadal ridges a...
|
»
Diabetes OD
»
Regeneration of Isle...
»
Stem Cells
»
Embryonic Stem Cells
»
In Vitro Derivation ...
»
Journal Article
submitted: Apr 05, 2006 |
|
44. (Journal Article): Human embryonic germ cell derivatives express a broad range of developmentally distinct markers and proliferate extensively in vitro.
Shamblott MJ, Axelman J, Littlefield JW, Blumenthal PD, Huggins GR, Cui Y, Cheng L, Gearhart JD ABSTRACT:
Human pluripotent stem cells (hPSCs) have been derived from the inner cell mass cells of blastocysts (embryonic stem cells) and primordial germ cells of the developing gonadal ridg...
|
»
Diabetes OD
»
Regeneration of Isle...
»
Stem Cells
»
Embryonic Stem Cells
»
In Vitro Derivation ...
»
Journal Article
submitted: Apr 05, 2006 |
|
45. (Journal Article): Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers.
Itskovitz-Eldor J, Schuldiner M, Karsenti D, Eden A, Yanuka O, Amit M, Soreq H, Benvenisty N ABSTRACT:
BACKGROUND: Embryonic stem (ES) cells are lines of cells that are isolated from blastocysts. The murine ES cells were demonstrated to be true pluripotent cells as they differentiat...
|
»
Diabetes OD
»
Regeneration of Isle...
»
Stem Cells
»
Embryonic Stem Cells
»
In Vitro Derivation ...
»
Journal Article
submitted: Apr 05, 2006 |
|
46. (Journal Article): Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture.
Amit M, Carpenter MK, Inokuma MS, Chiu CP, Harris CP, Waknitz MA, Itskovitz-Eldor J, Thomson JA ABSTRACT:
Embryonic stem (ES) cell lines derived from human blastocysts have the developmental potential to form derivatives of all three embryonic germ layers even after prolonged culture. ...
|
»
Diabetes OD
»
Regeneration of Isle...
»
Stem Cells
»
Embryonic Stem Cells
»
In Vitro Derivation ...
»
Journal Article
submitted: Apr 06, 2006 |
|
47. (Journal Article): NeuroD-betacellulin gene therapy induces islet neogenesis in the liver and reverses diabetes in mice.
Kojima H, Fujimiya M, Matsumura K, Younan P, Imaeda H, Maeda M, Chan L ABSTRACT:
To explore induced islet neogenesis in the liver as a strategy for the treatment of diabetes, we used helper-dependent adenovirus (HDAD) to deliver the pancreatic duodenal homeobox...
|
»
Diabetes OD
»
Regeneration of Isle...
»
Stem Cells
»
Other Cell Sources
»
Progenitors
»
Journal Article
submitted: May 19, 2005 |
|
48. (Journal Article): The Application of Umbilical Cord Blood Cells in the Treatment of Diabetes Mellitus
Koblas T, Harman SM, Saudek F ABSTRACT:
In recent years, human umbilical cord blood (HUCB) has emerged as an attractive tool for cell-based therapy. Although at present the clinical application of HUCB is limited to the ...
|
»
Diabetes OD
»
Regeneration of Isle...
»
Stem Cells
»
Other Cell Sources
»
Umbilical Cord Blood
»
Journal Article
submitted: Oct 03, 2006 |
|
49. (Journal Article): Human CD25+CD4+ T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function.
Levings MK, Sangregorio R, Roncarolo MG ABSTRACT:
Active suppression by T regulatory (Tr) cells plays an important role in the downregulation of T cell responses to foreign and self-antigens. Mouse CD4(+) Tr cells that express CD2...
|
»
Diabetes OD
»
Development and Func...
»
Immune System
»
Activation and Inhib...
»
Regulatory Mechanism...
»
Treg cells
»
T Cell Suppression
»
Journal Article
submitted: May 26, 2005 |
|
50. (Journal Article): CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes.
Tarbell KV, Yamazaki S, Olson K, Toy P, Steinman RM ABSTRACT:
In the nonobese diabetic (NOD) mouse model of type 1 diabetes, the immune system recognizes many autoantigens expressed in pancreatic islet beta cells. To silence autoimmunity, we ...
|
»
Diabetes OD
»
Development and Func...
»
Immune System
»
Activation and Inhib...
»
Regulatory Mechanism...
»
Treg cells
»
DC-induced
»
Journal Article
submitted: May 26, 2005 |
|